SCHEMBL4554300

SCHEMBL4554300

CCOC(=O)c1cc(I)c(=O)n(-n2cc(C(=O)OCC)cc(SCCO)c2=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.39
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA7 P43166 3/20 0.35
CA9 Q16790 3/20 0.35
CA14 Q9ULX7 3/20 0.35
MAPT P10636 2/20 0.35
PABPC1 P11940 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 3/20 0.34
HTT P42858 2/20 0.34
ESR1 P03372 3/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
BCL2L1 Q07817 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554301 0.74 FGFR1 (0.39) FGFR1CA12CA1CA2CA7
SCHEMBL3154774 0.70 ALDH1A1 (0.41) FGFR1CA12CA1CA2CA7
SCHEMBL23484286 0.64 ESR1 (0.69) CA12CA1CA2CA7CA9
SCHEMBL25456063 0.63 CA12 (0.55) CA12CA1CA2CA7CA9
SCHEMBL28417178 0.62 CA12 (0.61) CA12CA1CA2CA7CA9
SCHEMBL651934 0.62 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL2228061 0.60 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL30410030 0.60 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL1680787 0.60 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL16828921 0.60 JMJD6 (0.42) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2136807-A1 PYRROLO (3, 2, 1-IJ) QUINOLINE-4-ONE DERIVATIVES FOR TREATING TUBERCULOSIS Glaxo Group Limited (GB) 2009-12-30 EP disclosed
WO-2008125594-A1 PYRROLO (3, 2, 1-IJ) QUINOLINE-4-ONE DERIVATIVES FOR TREATING TUBERCULOSIS GLAXO GROUP LIMITED (GB) 2008-10-23 WO disclosed